Gain Therapeutics, Inc.
GANX
$1.65
-$0.04-2.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.84M | 8.81M | 6.69M | 9.07M | 10.39M |
| Total Receivables | 802.70K | 788.60K | 1.41M | 886.60K | 765.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 596.80K | 921.30K | 1.20M | 1.19M | 450.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.24M | 10.52M | 9.31M | 11.15M | 11.60M |
|
|
|||||
| Total Current Assets | 22.24M | 10.52M | 9.31M | 11.15M | 11.60M |
| Net Property, Plant & Equipment | 409.00K | 270.00K | 329.40K | 281.20K | 323.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 102.80K | 114.60K | 127.90K | 126.30K | 134.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 70.00K | 69.80K | 70.00K | 65.20K | 63.80K |
| Total Assets | 22.82M | 10.97M | 9.83M | 11.62M | 12.12M |
|
|
|||||
| Total Accounts Payable | 825.00K | 1.58M | 2.71M | 2.15M | 946.30K |
| Total Accrued Expenses | 2.26M | 2.29M | 2.17M | 2.38M | 2.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 220.70K | 241.50K | 262.40K | 261.80K | 271.10K |
| Total Finance Division Other Current Liabilities | 43.10K | 57.60K | 47.90K | 235.80K | 270.70K |
| Total Other Current Liabilities | 43.10K | 57.60K | 47.90K | 235.80K | 270.70K |
| Total Current Liabilities | 3.35M | 4.17M | 5.20M | 5.03M | 3.91M |
|
|
|||||
| Total Current Liabilities | 3.35M | 4.17M | 5.20M | 5.03M | 3.91M |
| Long-Term Debt | 300.10K | 298.80K | 325.40K | 314.50K | 328.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 211.20K | 65.00K | 92.90K | 30.60K | 53.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 390.50K | 527.80K | 522.70K | 470.90K | 491.10K |
| Total Liabilities | 4.25M | 5.06M | 6.14M | 5.84M | 4.78M |
|
|
|||||
| Common Stock & APIC | 119.14M | 102.16M | 94.65M | 91.62M | 88.78M |
| Retained Earnings | -101.36M | -96.82M | -91.53M | -85.73M | -81.19M |
| Treasury Stock & Other | 776.90K | 563.20K | 584.10K | -119.90K | -247.50K |
| Total Common Equity | 18.56M | 5.91M | 3.70M | 5.78M | 7.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.56M | 5.91M | 3.70M | 5.78M | 7.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.56M | 5.91M | 3.70M | 5.78M | 7.34M |
|
|
|||||